| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $3.72M | $4.06M | $3.19M | $3.93M | $2.17M |
| R&D | $2.31M | $2.33M | $1.85M | $2.35M | $1.10M |
| SG&A | $1.41M | $1.73M | $1.34M | $1.54M | $1.03M |
| Operating Income | -$3.72M | -$4.06M | -$3.19M | -$3.93M | -$2.17M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$2.87M | -$1.42M | -$3.06M | -$3.96M | -$2.14M |
| EPS (basic) | -0.0090 | -0.0050 | -0.0100 | -0.0140 | -0.0080 |
| EPS (diluted) | -0.0090 | -0.0050 | -0.0100 | – | – |
| Shares (diluted) | $312.19M | $303.85M | $299.95M | – | – |